Improvement in vascular function with low-dose folic acid supplementation: Implications for folate therapy and dietary fortification

Bibliographic Details
Main Authors:	Shirodaria, C, Antoniades, C, Lee, J, Jackson, C, Francis, J, Robson, M, Ratnatunga, C, Pillai, R, Neubauer, S, Channon, K
Format:	Conference item
Published:	2007

Global improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery disease.
by: Shirodaria, C, et al.
Published: (2007)

No additional improvement in vascular function with high dose vs. low dose folic acid in coronary artery disease - Implications for HOPE-2
by: Shirodaria, C, et al.
Published: (2006)

Folic acid induces maximal vascular effects at dosage equivalent to the recommended daily allowance (RDA): Implications for folic acid treatment in fortified populations
by: Antoniades, C, et al.
Published: (2007)

Short-term folic acid treatment improves central and peripheral vascular function in patients with coronary artery disease - A cardiovascular magnetic resonance study
by: Shirodaria, C, et al.
Published: (2006)

Global improvements in both central and peripheral vascular function after short-term folic acid treatment in patients with coronary artery disease - A cardiovascular MR study
by: Shirodaria, C, et al.
Published: (2005)

Low- and high- dose treatment with folic acid, equally improve endothelial function and decrease superoxide production in human vessels via tetrahydrobiopterin-mediated eNOS coupling
by: Antoniades, C, et al.
Published: (2007)

Chronic treatment with folic acid improves endothelial function and decreases superoxide production in human vessels. A double blind placebo control study
by: Shirodaria, C, et al.
Published: (2005)

Direct improvement of endothelial function and superoxide production in human vessels, by oral folic acid treatment: A double blind placebo controlled study
by: Antoniades, C, et al.
Published: (2005)

Chronic treatment with folic acid improves nitric oxide bioavailability and decreases superoxide production in human vessels, through tetrahydrobiopterin-mediated improvement of eNOS coupling
by: Antoniades, C, et al.
Published: (2007)

Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials.
by: Antoniades, C, et al.
Published: (2009)

Intravenous infusion of 5-methyl-tetrahydrofolate rapidly improves eNOS Coupling. In human vessels by increasing tetrahydrobiopterin bioavailability
by: Antoniades, C, et al.
Published: (2006)

Maternal folic acid supplementation and dietary folate intake and congenital heart defects.
by: Baohong Mao, et al.
Published: (2017-01-01)

Multi-modal magnetic resonance imaging quantifies atherosclerosis and vascular dysfunction in patients with type 2 diabetes mellitus.
by: Lee, J, et al.
Published: (2007)

Direct effects of 5-methyl-tetrahydrofolate on vascular endotheliurn and superoxide production in human arteries and veins
by: Antoniades, C, et al.
Published: (2006)

Effects of 5-methyl-tetrahydrofolic acid on endothelial function and vascular superoxide production in human coronary artery disease
by: Antoniades, C, et al.
Published: (2006)

The common genetic polymorphism C677T of methyltetrahydrofolate reductase regulates nitric oxide bioavailability and vascular superoxide production via modulation of eNOS coupling in human vessels
by: Antoniades, C, et al.
Published: (2007)

Mandatory food fortification with folic acid
by: Anita Kar, et al.
Published: (2022-10-01)

High folate levels in Aboriginal children after subsidised fruit and vegetables and mandatory folic acid fortification
by: Andrew P. Black, et al.
Published: (2014-06-01)

5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling.
by: Antoniades, C, et al.
Published: (2006)

Rapid effects of 5-methyl-tetrahydrofolic acid on endothelial function and vascular superoxide production in human coronary artery disease
by: Antoniades, C, et al.
Published: (2006)

Plasma asymmetrical-dimethyl-arginine (ADMA) regulates nitric oxide bioavailability and vascular superoxide production in human vessels
by: Antoniades, C, et al.
Published: (2007)

Polymorphism of MTHFR gene affects vascular redox and nitric oxide bioavailability by modifying eNOS coupling
by: Antoniades, C, et al.
Published: (2008)

Plasma asymmetrical-dimethyl-arginine (ADMA) as a regulator of vascular redox and nitric oxide bioavailability in human vessels
by: Antoniades, C, et al.
Published: (2007)

Early comprehensive characterisation of the vascular response to statin treatment using MRI
by: Lee, J, et al.
Published: (2006)

Relationships between vascular/plasma biopterins and endothelial nitric oxide synthase coupling, endothelial function and inflammation, in human atherosclerosis
by: Antoniades, C, et al.
Published: (2008)

Genetic variability of MTHFR affects vascular redox and nitric oxide bioavailability in human vessels, by modifying eNOS coupling
by: Antoniades, C, et al.
Published: (2008)

Plasma asymmetrical-dimethyl-arginine affects eNOS vascular superoxide radical production and nitric oxide bioavailability in human arteries and veins
by: Antoniades, C, et al.
Published: (2008)

5-methyl-tetrahydrofolate increases eNOS activity by preventing peroxynitrite-induced oxidation of tetrahydrobiopterin in human vessels
by: Antoniades, C, et al.
Published: (2006)

Mandatory food fortification with folic acid
by: Gabriela Cormick, et al.
Published: (2022-10-01)

Mandatory food fortification with folic acid
by: A David Smith, et al.
Published: (2022-10-01)

Impact of Voluntary Folic Acid Fortification of Corn Masa Flour on RBC Folate Concentrations in the U.S. (NHANES 2011–2018)
by: Arick Wang, et al.
Published: (2021-04-01)

5-Methyl-tetrahydrofolate acid improves endothelial function and decreases superoxide production by improving eNOS coupling and increasing tetrahydrobiopterin bioavailability in human vessels in vivo
by: Antoniades, C, et al.
Published: (2006)

5-methyl-tetrahydrofolate acid improves endothelial function and decreases superoxide production in vessels from patients with coronary artery disease
by: Antoniades, C, et al.
Published: (2006)

5-methyl-tetrahydrofolic acid increases nitric oxide bioavailability and decreases superoxide production by improving eNOS coupling in human vessels in vivo: Effects on intracellular tetrahydrobiopterin oxidation
by: Antoniades, C, et al.
Published: (2006)

Maternal Folic Acid Supplementation, Dietary Folate Intake, and Low Birth Weight: A Birth Cohort Study
by: Liping Yang, et al.
Published: (2022-06-01)

Soluble CD40-ligand levels are associated with vascular superoxide production and eNOS coupling in human vessels: Interrelationships with homocysteine biosynthetic pathway
by: Antoniades, C, et al.
Published: (2008)

Statin treatment rapidly reduces aortic atherosclerosis and improves vascular function: A cardiovascular magnetic resonance study
by: Lee, J, et al.
Published: (2006)

Chronic oral tetrahydrobiopterin therapy in coronary artery disease elevates total biopterin levels but does not improve redox status or vascular function: a randomized placebo-controlled trial
by: Cunnington, C, et al.
Published: (2010)

Folic acid fortification and public health: Report on threshold doses above which unmetabolised folic acid appear in serum
by: McPartlin Joseph, et al.
Published: (2007-03-01)

Concentrations of blood folate in Brazilian studies prior to and after fortification of wheat and cornmeal (maize flour) with folic acid: a review
by: Jéssica Carrilho Britto, et al.
Published: (2014-07-01)

Improvement in vascular function with low-dose folic acid supplementation: Implications for folate therapy and dietary fortification

Similar Items

Similar Items